Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist representation of a medical isotope symbol shielded by an outline.

Jun 8, 2026

Netherlands Expands Vital Investment Screening to Shield AI and Biotech

The Dutch government has expanded its foreign direct investment screening to safeguard its artificial intelligence and biotechnology sectors amid rising geopolitical tensions.This significant update to the Screening of Investments, Mergers and Acquisitions Act, originally established to protect critical infrastructure, now encompasses a wider range of technologies. The forthcoming regulations will subject foreign investments in AI, biotech, advanced materials, nanotechnology, and medical isotope
A genomic sample in a petri dish on a lab bench

Jun 8, 2026

Disruptive healthtech, personalisation & investment appetite

The rapid evolution of healthtech, driven by AI, genomics, and personalized medicine, is capturing significant attention from both investors and industry stakeholders. However, the journey from innovative concept to market-ready solution is becoming increasingly intricate, as companies must demonstrate substantive value amidst growing scrutiny.In a recent discussion, Nat Hutley, co-founder and CEO of Koodos, highlighted that investors are particularly drawn to healthtech firms that leverage data
A stethoscope on a medical chart in a dimly lit clinic room

Jun 8, 2026

Cardiolife Partners with Bhutan Ministry of Health to Strengthen Nationwide Cardiac Care

Cardiolife has formed a significant partnership with Bhutan's Ministry of Health to implement its AI-driven ECG diagnostics system nationwide, aiming to enhance cardiac care and preventive health measures in the country.This initiative comes at a crucial time, as cardiac diseases are among the leading health challenges in Bhutan, which has a population of over 700,000. The Health Minister, Lyonpo Tandin Wangchuk, has officially endorsed this collaboration, emphasizing the importance of early det
Minimalist illustration of a prostate gland and biopsy needle on a dark background.

Jun 8, 2026

M42 brings AI-driven prostate cancer diagnostics to the UAE

M42 is introducing AI-enhanced diagnostics for prostate cancer in the UAE, addressing a significant health challenge in the region.Prostate cancer is increasingly prevalent in the Middle East, with officials reporting around 50,000 new cases annually. The traditional methods for reviewing and grading biopsies are often intricate and lengthy, which can result in delays in obtaining diagnoses for patients. M42's AI-driven approach aims to streamline this process, potentially improving both accurac
Minimalist illustration of a heart and ECG waveform

Jun 8, 2026

Heart Attack Diagnostics Market Size, Share | CAGR of 8.7%

The Global Heart Attack Diagnostics Market is poised for significant growth, projected to reach approximately $25.8 billion by 2034, up from $11.2 billion in 2024, reflecting a compound annual growth rate (CAGR) of 8.7% over the next decade.This market expansion is driven by several factors, including the rising incidence of cardiovascular diseases and advancements in diagnostic technologies. Heart attack diagnostics, which encompass clinical assessments, imaging techniques, and laboratory tests
Endobronchial ultrasound probe and lung tissue sample in a clinical setting.

Jun 8, 2026

United States Endobronchial Ultrasound Biopsy Market Set for Steady Growth Through 2033 as Minimally Invasive Lung Diagnostics Gain Momentum

The U.S. Endobronchial Ultrasound (EBUS) biopsy market is poised for steady growth, driven by the increasing demand for minimally invasive lung diagnostics. As healthcare providers seek safer and more effective diagnostic methods, EBUS is becoming a preferred alternative to traditional surgical procedures.According to projections, the market is expected to expand from approximately $246.82 billion in 2024 to $356.2 billion by 2033, reflecting a compound annual growth rate (CAGR) of 4.16%. This g
A minimalist illustration of a semiconductor chip on a solid background.

Jun 8, 2026

EU proposes tech sovereignty package to boost chips, AI, cloud and open source capabilities

The European Commission has unveiled a comprehensive "Technological Sovereignty Package" aimed at bolstering the EU's self-sufficiency in critical digital technologies, including semiconductors, AI, cloud services, and open-source software.This initiative merges two significant legislative proposals: the Chips Act 2.0 and the Cloud and AI Development Act, along with an updated Open Source Strategy. The primary goals include expediting approvals for chip manufacturing projects, enhancing partners
A test tube with a colorful liquid on a lab bench

Jun 8, 2026

R1 Capital Launches As Dedicated Venture Firm Focused On Enterprise AI, Deep Tech, And Life Sciences

R1 Capital has officially launched as a dedicated venture firm aimed at supporting innovators in enterprise AI, deep tech, and life sciences, focusing on solving significant challenges in underfunded markets.Previously part of Rev1 Ventures, R1 Capital is now an independent entity with its own investment strategy and branding. The firm aims to fill a gap in venture funding, particularly for founders who might struggle to secure capital from larger coastal firms. This initiative comes amid a tren
A minimalist representation of a mass spectrometer and a molecule in a dark color scheme.

Jun 8, 2026

Did New Orbitrap and AI Proteomics Launches Just Reframe Thermo Fisher Scientific's (TMO) Tools Integration Story?

Thermo Fisher Scientific has introduced its new Orbitrap Tribrid Apex and Orbitrap Excedion mass spectrometers, showcasing advancements in multiomics and AI-enabled proteomics at the recent American Society for Mass Spectrometry Conference. These innovations aim to enhance the detection of low-abundance molecules, thereby supporting complex biopharmaceutical research and regulatory compliance.The launches are significant as they reinforce Thermo Fisher's strategy to bridge early biological disco
A minimalist illustration of a test tube with a drop of liquid, representing laboratory efficiency.

Jun 8, 2026

Scispot Raises $8 Million Series A To Help Life Sciences Labs Move Faster

Scispot, a Canadian startup focused on enhancing laboratory efficiency through AI, has successfully secured $8 million in Series A funding, led by Avenue Growth Partners. This investment aims to further develop its innovative platform, which is currently utilized by over 100 labs across various life sciences sectors, including biotech and pharmaceuticals.Located in Kitchener-Waterloo, Ontario, Scispot addresses the common challenges faced by modern laboratories, which often operate with fragment
A stack of coins on a wooden desk in a dimly lit office

Jun 8, 2026

Merantix Capital Raises €103 Million AI Fund To Back Early-Stage European Startups

Merantix Capital has successfully closed a €103 million fund aimed at nurturing early-stage, AI-driven startups throughout Europe. This initiative is part of a broader strategy to leverage artificial intelligence in transforming various industrial sectors, including healthcare and life sciences.The fund is designed to invest in around 40 companies at various stages, from pre-idea to seed, emphasizing the importance of AI solutions in industries such as logistics, energy, and finance. Merantix Ca
A blood sample in a vial on a lab bench with a microscope behind it.

Jun 8, 2026

Our vision is to make genomics as commonplace as BP monitor: Dr. Ramesh Hariharan, Chief Executive Officer, Strand Life Sciences

Strand Life Sciences is positioning itself to integrate genomics into everyday healthcare, aiming to make genomic insights as commonplace as traditional monitoring tools like blood pressure monitors. In a recent interview, CEO Dr. Ramesh Hariharan discussed the company's strategic evolution in precision medicine, diagnostics, and consumer genomics.As precision medicine gains traction in India, Strand Life Sciences is expanding its focus from enterprise bioinformatics to include diagnostics and p